Literature DB >> 14501163

Orexin receptors and G-protein coupling: evidence for another "promiscuous" seven transmembrane domain receptor.

Emmanouil Karteris, Harpal S Randeva.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14501163     DOI: 10.1254/jphs.93.126

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


× No keyword cloud information.
  11 in total

1.  Orexins/hypocretins act in the posterior paraventricular thalamic nucleus during repeated stress to regulate facilitation to novel stress.

Authors:  Willem Heydendael; Kanika Sharma; Vikram Iyer; Sandra Luz; David Piel; Sheryl Beck; Seema Bhatnagar
Journal:  Endocrinology       Date:  2011-10-04       Impact factor: 4.736

2.  Orexins stimulate steroidogenic acute regulatory protein expression through multiple signaling pathways in human adrenal H295R cells.

Authors:  Manjunath Ramanjaneya; Alex C Conner; Jing Chen; Peter R Stanfield; Harpal S Randeva
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

3.  Orexin A-mediated stimulation of 3β-HSD expression and testosterone production through MAPK signaling pathways in primary rat Leydig cells.

Authors:  D Zheng; Y Zhao; Y Shen; X Chang; S Ju; L Guo
Journal:  J Endocrinol Invest       Date:  2014-03       Impact factor: 4.256

4.  Optogenetic examination identifies a context-specific role for orexins/hypocretins in anxiety-related behavior.

Authors:  W Heydendael; A Sengupta; S Beck; S Bhatnagar
Journal:  Physiol Behav       Date:  2013-10-18

5.  Orexins/hypocretins acting at Gi protein-coupled OX 2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures.

Authors:  Anna Urbańska; Paulina Sokołowska; Agata Woldan-Tambor; Kaja Biegańska; Britta Brix; Olaf Jöhren; Magdalena Namiecińska; Jolanta Barbara Zawilska
Journal:  J Mol Neurosci       Date:  2011-05-06       Impact factor: 3.444

6.  Orexin A Affects INS-1 Rat Insulinoma Cell Proliferation via Orexin Receptor 1 and the AKT Signaling Pathway.

Authors:  Li Chen; Yuyan Zhao; Delu Zheng; Shujing Ju; Yang Shen; Lei Guo
Journal:  Int J Endocrinol       Date:  2013-12-08       Impact factor: 3.257

7.  The Orexin-A-Regulated Akt/mTOR Pathway Promotes Cell Proliferation Through Inhibiting Apoptosis in Pancreatic Cancer Cells.

Authors:  Linna Suo; Xiaocen Chang; Yuyan Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-31       Impact factor: 5.555

8.  Acute suppressive and long-term phase modulation actions of orexin on the mammalian circadian clock.

Authors:  Mino D C Belle; Alun T L Hughes; David A Bechtold; Peter Cunningham; Massimo Pierucci; Denis Burdakov; Hugh D Piggins
Journal:  J Neurosci       Date:  2014-03-05       Impact factor: 6.167

9.  Orexin receptors exert a neuroprotective effect in Alzheimer's disease (AD) via heterodimerization with GPR103.

Authors:  Julie Davies; Jing Chen; Ryan Pink; David Carter; Nigel Saunders; Georgios Sotiriadis; Bo Bai; Yanyou Pan; David Howlett; Annette Payne; Harpal Randeva; Emmanouil Karteris
Journal:  Sci Rep       Date:  2015-07-30       Impact factor: 4.379

10.  Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.

Authors:  Xing Wan; Yuanyuan Liu; Yuyan Zhao; Xiaoqi Sun; Dongxiao Fan; Lei Guo
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.